-
Research/Studies
Addex Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
Addex Therapeutics announced publication of new preclinical research demonstrating that ADX71743, a selective negative allosteric modulator (NAM) of metabotropic glutamate receptor 7 (mGlu7), significantly modulates sleep-wake regulation and stress-related neurochemistry in animal models. The data, published in the International Journal of Neuropsychopharmacology, expands the growing body of evidence supporting mGlu7 […]
-
Apps/Artificial Intelligence, Industry News
sovaSage Introduces AI-Powered Clinical Indicator Intelligence to Advance PAP Patient Management
sovaSage™ announced the new release of Clinical Indicator Intelligence™, an enhanced feature within sovaGuide™ featuring Jeanie™. Using machine learning, the new capability continuously analyzes multiple PAP therapy variables to help providers identify patients who may require additional clinical evaluation before therapy challenges lead to reduced benefit or treatment abandonment. The […]
-
Industry News
Resmed Announces Agreement to Sell MatrixCare Business
Resmed announced it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused exclusively on health care. This move reflects Resmed’s 2030 strategy by focusing on high-growth, scalable opportunities in sleep health, breathing health and connected home-based healthcare. The divestiture […]
-
Industry News, Sleep-Disordered Breathing
Ognomy Sleep Raises $20M Series A to Expand AI-Enabled Sleep Apnea Care
Ognomy Sleep, announced the closing of a $20 million Series A financing round led by Catalyst Investors, with participation from Blue Heron Capital. The round also included new and follow-on investments from Impellent Ventures, LaunchNY, Excell and Upstate Biotech Ventures, University of Buffalo, and strategic partners who have supported the company’s […]
Latest News
HST
-
Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker
June 10, 2026[...] -
Wesper to Unveil First Multi-Tier Sleep Diagnostic Ecosystem for Personalized Sleep Care at SLEEP 2026
June 10, 2026[...] -
Why HST is Underutilized—and How to Fix It
April 6, 2026[...]
- Techno Xperts Builds Sleep Diagnostics Distribution Platform for Latin America
- Patch-Based Onera Sleep Test Demonstrates PSG Accuracy Outside the Sleep Lab
- The Future is Hybrid: Blending In-lab Expertise With Remote Diagnostics
Research
-
Addex Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
July 9, 2026[...] -
Monash University and Brigham and Women’s Hospital to Advance Innovation in Sleep and Circadian Medicine
June 30, 2026[...] -
The Syn-Sleep Study: Detection of Cutaneous Phosphorylated Alpha-Synuclein in REM Sleep Behavior Disorder
June 19, 2026[...]
- Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker
- Wesper to Unveil First Multi-Tier Sleep Diagnostic Ecosystem for Personalized Sleep Care at SLEEP 2026
- New Survey Results Explore the Complexity of Marijuana Use and Sleep
Pharmaceuticals
-
ŌURA and LillyDirect to Expand Support for People Using GLP-1 Therapies with New Tools and Savings Options
June 24, 2026[...] -
Jazz Delivers Extensive Data at SLEEP 2026, Real-World Impact of Xywav on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia
June 19, 2026[...] -
New Study: Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for Narcolepsy Type 1
June 17, 2026[...]
- Jazz Pharmaceuticals to Present Data at SLEEP 2026 Highlighting Effects of Xywav for Narcolepsy and Idiopathic Hypersomnia
- Alkermes Presents Phase 2 Alixorexton Data in Narcolepsy Type 1 at AAN 2026
- Clinical Trial of Early Morning Shift Workers Shows Promise of New Drug for Reducing Excessive Sleepiness
SleepWorld Magazine Articles
-
Inside the Making of the RPSGT Exam | Viewpoint from the BRPT
May 13, 2026For sleep technologists, earning the Registered Polysomnographic Technologist (RPSGT) credential is a major professional [...] -
Weight Loss Medications and Sleep Apnea
April 29, 2026The rise in GLP-1 medications for weight loss is undeniable. The amount of money Americans spent on GLP-1 medications skyrocketed [...] -
1st Annual Reader Tech Survey
April 7, 2026Even if you’re not one to make New Year’s resolutions, the start of a new year naturally invites reflection on what worked [...]
- Why HST is Underutilized—and How to Fix It
- NOCTEM Health
- Home Sleep Testing – No Business for Dentists?
Dental Sleep Medicine
-
ProSomnus and MonitAir Collaborate to Enhance Connected Care for OSA
June 19, 2026ProSomnus Sleep Technologies (“ProSomnus”), pioneer of Smart Sleep Medicine™, and MonitAir, LLC (“MonitAir”), the [...] -
Elevating Dental Sleep
May 19, 2026Over the past 15 years, I have watched sleep medicine evolve through a number of transformative cycles—from lab-dominant [...] -
Great Lakes Dental Technologies Names David Josza New President and Chief Executive Officer
May 18, 2026David Josza was recently named Great Lakes new president and chief executive officer. Mr. Josza assumed his new role on May 11, [...]
- Nihon Kohden Brings NomadAir with Connect to Dental Sleep Medicine, Connecting Providers for Faster, Smarter Care
- Weight Loss Medications and Sleep Apnea
- Great Lakes Dental Technologies Partners with TAP Sleep Care for Nylon flexTAP Launch




























